L-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid, 98.0%, 5g

2,5-Dichlorothiazolo[4,5-b]pyridine, 98%, 10g

Lead(IV) oxide, min. 97%, pa, 100 g, plastic packaging.

Benzothiazol-4-ylamine, 95.0%, 500mg

2-HYDROXY-1-(MORPHOLIN-4-YL)ETHAN-1-ONE, 95.0%, 100g

5-(4-Methylpiperazin-1-yl)-1H-1,2,4-triazol-3-amine, 95.0%, 250mg

2-(Chloromethyl)-5-methyl-1,3,4-oxadiazole, 95.0%, 25g

ethyl 2-hydroxy-4-oxo-4-[3-(trifluoromethyl)phenyl]but-2-enoate, 95%, 2.5g

Dialysis membrane Spectra/Por® 1 to 4 Spectra/Por® 1 - MWCO 6000 to 8000, 10 mm, 15 m, 1 Piece(s)

6-Fluoro-1H-indol-4-amine, 95.0%, 250mg

2,5-dioxopyrrolidin-1-yl 5-(4-(1,2,4,5-tetrazin-3-yl)benzylamino)-5-oxopentanoate, 98%, 10mg

D-7-Azatryptophan, 97.0%, 1g

2-(Ethoxymethyl)furan, 98.0%, 5g